Tag: Australian Institute of Bioengineering and Nanotechnology
Starpharma launches R&D partnership with UQ to advance DEP cancer treatment products
Biopharmaceutical company Starpharma Holdings has ventured into a partnership with the University of Queensland’s (UQ) Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR Hub) to advance research and development on the ASX company’s targeted DEP radiotheranostic products.
Featured Article
From cost exposure to cost control: Using energy flexibility to protect margins
Electricity price volatility is reshaping the cost base of Australian manufacturing, challenging long-held assumptions that energy can be treated as a stable operational input.
